8 results
Suggested algorithm for bone marrow biopsy and skeletal imaging in patients with monoclonal gammopathy of undetermined
Suggested algorithm ... IgM MGUS, low-risk ... lymphoplasmacytic malignancy ... #diagnosis #management ... #hematology #multiplemyeloma
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... patients at high risk ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
A priority in this project was to appropriately stratify participants into a low, medium, or high-intensity
group-based exercise class ... The classification ... for Fall Risk Assessment ... STEADI) #Diagnosis #Management ... #Fall #Risk #Screening
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
Diagnosis and Management ... Algorithm Lifestyle ... • Secondary Causes ... #algorithm #DM2 ... #DMII #Classification
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
hematological malignancy ... Hodgkin Lymphoma Risk ... ) Classification ... #hematology #oncology ... #management
Post-Transplantation Lymphoproliferative Disorders (PTLD)
Definition: Lymphoid and/or plasmacytic proliferations that occur as a result of immunosuppression in
immunocompetent population Risk ... symptoms, unexplained hematologic ... Diagnosis and classification ... to 50% of PTLD cases ... oncology #diagnosis #management
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Most cases are related ... • Treatment algorithms ... patients with no CV risk ... #diagnosis #management ... #hematology